EP01.08: Artificial intelligence to assist in the screening fetal anomaly ultrasound scan (PROMETHEUS): a randomised controlled trial.

A randomized controlled trial was conducted to assess the effectiveness of an artificial intelligence (AI) tool in assisting with fetal anomaly screening ultrasound scans. The study found that the AI-assisted scans had a higher sensitivity and specificity in detecting congenital heart disease (CHD) compared to standard scans. Additionally, the AI-assisted scans were significantly shorter in duration and resulted in a lower cognitive load for sonographers. The study also found that the AI tool provided highly repeatable and reproducible biometric measurements. Further research is being conducted to integrate disease detection models into the AI tool. [Extracted from the article]

Copyright of Ultrasound in Obstetrics & Gynecology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)